Affiliation: Karolinska Institutet
- Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptomsYvonne Freund-Levi
Department of NVS, Section of Clinical Geriatrics, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden
Int J Geriatr Psychiatry 23:161-9. 2008..An association with APOEomega4 carriers and neuropsychiatric symptoms in AD has also been suggested...
- Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD studyYvonne Freund-Levi
Department NVS, Division of Clinical Geriatrics, Karolinska University Hospital, Stockholm, Sweden
Dement Geriatr Cogn Disord 27:481-90. 2009..omega-3 fatty acids (omega-3 FAs) found in dietary fish or fish oils are anti-inflammatory agents that may influence Alzheimer's disease (AD)...
- Reduced prostaglandin F2 alpha release from blood mononuclear leukocytes after oral supplementation of omega3 fatty acids: the OmegAD studyInger Vedin
Department of Medicine, Caring Sciences and Society, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
J Lipid Res 51:1179-85. 2010..The stimulus-specific PGF(2alpha) release from PBMC after 6 months of oral supplementation with the DHA-rich fish oil might be one event related to reduced inflammatory reactions associated with omega-3 fatty acid intake...
- Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD studyInger Vedin
Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
PLoS ONE 7:e35425. 2012..Hence, our aim was to determine the effects of 6 mo of dietary supplementation with an n-3 FA preparation rich in DHA on global gene expression in peripheral blood mononuclear cells...
- Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trialYvonne Freund-Levi
Department of Neurobiology, Caring Sciences and Society, Section of Clinical Geriatrics, Karolinska University Hospital Huddinge, Stockholm
Arch Neurol 63:1402-8. 2006..However, positive effects were observed in a small group of patients with very mild AD (MMSE >27 points)...
- Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: the omega-3 Alzheimer's disease studyGerd Faxén Irving
Department of Neurobiology, Karolinska Institutet, Karolinska University, Hospital Huddinge, Stockholm, Sweden
J Am Geriatr Soc 57:11-7. 2009..To study the effects of omega (Omega)-3 fatty acid (FA) supplements on weight and appetite in patients with mild to moderate Alzheimer's disease (AD) in relation to inflammatory biomarkers and apolipoprotein E epsilon4 (APOEepsilon4)...
- [Omega-3-fatty acids protect against dementia. Also early symptoms of mild Alzheimer disease seem to be inhibited]Jan Palmblad
, Karolinska institutet och Karolinska Universitetssjukhuset Huddinge
Lakartidningen 104:3268-71. 2007
- Immunomodulation of microglia by docosahexaenoic acid and eicosapentaenoic acidErik Hjorth
Division of Neurodegeneration, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
Curr Opin Clin Nutr Metab Care 15:134-43. 2012..In this review, we present and discuss findings on the modulation of microglial activities by ω-3 FAs in vivo as well as in vitro, and propose mechanisms for their effects...
- [Administration of symptom-relieving drugs in Alzheimer disease is beneficial]Agneta Nordberg
Geriatriska kliniken, Karolinska Universitetssjukhuset, Huddinge
Lakartidningen 103:369-71. 2006